DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase

Abstract

3-Hydroxypyrimidine-2,4-dione (HPD) represents a versatile chemical core in the design of inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated RNase H and integrase strand transfer (INST). We report herein the design, synthesis and biological evaluation of an HPD subtype (4) featuring a cyclohexylmethyl group at the C-6 position. Antiviral testing showed that most analogues of 4 inhibited HIV-1 in the low nanomolar to submicromolar range, without cytotoxicity at concentrations up to 100 μM. Biochemically, these analogues dually inhibited both the polymerase (pol) and the RNase H functions of RT, but not INST. Co-crystal structure of 4a with RT revealed a nonnucleoside RT inhibitor (NNRTI) binding mode. Interestingly, chemotype 11, the synthetic precursor of 4 lacking the 3-OH group, did not inhibit RNase H while potently inhibiting pol. Here, by virtue of the potent antiviral activity and biochemical RNase H inhibition, HPD subtype 4 could provide a viable platform for eventually achieving potent and selective RNase H inhibition through further medicinal chemistry.

Authors:
 [1];  [2];  [2];  [2];  [2];  [1];  [2];  [1]
  1. Univ. of Minnesota, Minneapolis, MN (United States)
  2. Univ. of Missouri School of Medicine, Columbia, MO (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC); National Inst. of Health
OSTI Identifier:
1349118
Alternate Identifier(s):
OSTI ID: 1419352
Grant/Contract Number:  
AC02-06CH11357; AI100890
Resource Type:
Accepted Manuscript
Journal Name:
European Journal of Medicinal Chemistry
Additional Journal Information:
Journal Volume: 128; Journal Issue: C; Journal ID: ISSN 0223-5234
Publisher:
Elsevier
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES; 3-Hydroxypyrimidine-2,4-dione (HPD); human immunodeficiency virus (HIV); RNase H; polymerase; inhibitors

Citation Formats

Tang, Jing, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Ji, Juan, Wilson, Daniel J., Sarafianos, Stefan G., and Wang, Zhengqiang. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. United States: N. p., 2017. Web. doi:10.1016/j.ejmech.2017.01.041.
Tang, Jing, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Ji, Juan, Wilson, Daniel J., Sarafianos, Stefan G., & Wang, Zhengqiang. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. United States. https://doi.org/10.1016/j.ejmech.2017.01.041
Tang, Jing, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Ji, Juan, Wilson, Daniel J., Sarafianos, Stefan G., and Wang, Zhengqiang. Mon . "6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase". United States. https://doi.org/10.1016/j.ejmech.2017.01.041. https://www.osti.gov/servlets/purl/1349118.
@article{osti_1349118,
title = {6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase},
author = {Tang, Jing and Kirby, Karen A. and Huber, Andrew D. and Casey, Mary C. and Ji, Juan and Wilson, Daniel J. and Sarafianos, Stefan G. and Wang, Zhengqiang},
abstractNote = {3-Hydroxypyrimidine-2,4-dione (HPD) represents a versatile chemical core in the design of inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated RNase H and integrase strand transfer (INST). We report herein the design, synthesis and biological evaluation of an HPD subtype (4) featuring a cyclohexylmethyl group at the C-6 position. Antiviral testing showed that most analogues of 4 inhibited HIV-1 in the low nanomolar to submicromolar range, without cytotoxicity at concentrations up to 100 μM. Biochemically, these analogues dually inhibited both the polymerase (pol) and the RNase H functions of RT, but not INST. Co-crystal structure of 4a with RT revealed a nonnucleoside RT inhibitor (NNRTI) binding mode. Interestingly, chemotype 11, the synthetic precursor of 4 lacking the 3-OH group, did not inhibit RNase H while potently inhibiting pol. Here, by virtue of the potent antiviral activity and biochemical RNase H inhibition, HPD subtype 4 could provide a viable platform for eventually achieving potent and selective RNase H inhibition through further medicinal chemistry.},
doi = {10.1016/j.ejmech.2017.01.041},
journal = {European Journal of Medicinal Chemistry},
number = C,
volume = 128,
place = {United States},
year = {Mon Jan 30 00:00:00 EST 2017},
month = {Mon Jan 30 00:00:00 EST 2017}
}

Journal Article:

Citation Metrics:
Cited by: 21 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Update on HAART in HIV
journal, January 2006


Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
journal, January 2010


Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
journal, January 2016


Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection
journal, August 2015

  • Park, Tae Eun; Mohamed, Abdilahi; Kalabalik, Julie
  • Expert Review of Anti-infective Therapy, Vol. 13, Issue 10
  • DOI: 10.1586/14787210.2015.1075393

Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H
journal, April 2016


3-Hydroxypyrimidine-2,4-dione-5- N -benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H
journal, June 2016


Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase
journal, July 2007

  • Wang, Zhengqiang; Bennett, Eric M.; Wilson, Daniel J.
  • Journal of Medicinal Chemistry, Vol. 50, Issue 15
  • DOI: 10.1021/jm070512p

3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
journal, April 2011

  • Tang, Jing; Maddali, Kasthuraiah; Metifiot, Mathieu
  • Journal of Medicinal Chemistry, Vol. 54, Issue 7
  • DOI: 10.1021/jm1014378

N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase
journal, October 2010

  • Tang, Jing; Maddali, Kasthuraiah; Dreis, Christine D.
  • ACS Medicinal Chemistry Letters, Vol. 2, Issue 1
  • DOI: 10.1021/ml1002162

Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
journal, January 2011

  • He, Yan-Ping; Long, Jin; Zhang, Shui-Shuan
  • Bioorganic & Medicinal Chemistry Letters, Vol. 21, Issue 2
  • DOI: 10.1016/j.bmcl.2010.12.003

A Safe, Economical Method for the Preparation of β-Oxo Esters
journal, January 1993

  • Clay, Ronald J.; Collom, Thomas A.; Karrick, Gregory L.
  • Synthesis, Vol. 1993, Issue 03
  • DOI: 10.1055/s-1993-25849

Clicking 3′-Azidothymidine into Novel Potent Inhibitors of Human Immunodeficiency Virus
journal, October 2013

  • Sirivolu, Venkata Ramana; Vernekar, Sanjeev Kumar V.; Ilina, Tatiana
  • Journal of Medicinal Chemistry, Vol. 56, Issue 21
  • DOI: 10.1021/jm401232v

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
journal, December 1983


Retroviral integrase superfamily: the structural perspective
journal, January 2009


Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors
journal, January 1996

  • Hopkins, Andrew L.; Ren, Jingshan; Esnouf, Robert M.
  • Journal of Medicinal Chemistry, Vol. 39, Issue 8
  • DOI: 10.1021/jm960056x

Design of MKC-442 (Emivirine) Analogues with Improved Activity Against Drug-Resistant HIV Mutants
journal, November 1999

  • Hopkins, Andrew L.; Ren, Jingshan; Tanaka, Hiromichi
  • Journal of Medicinal Chemistry, Vol. 42, Issue 22
  • DOI: 10.1021/jm990192c

A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
journal, December 1989

  • Miyasaka, Tadashi; Tanaka, Hiromichi; Baba, Masanori
  • Journal of Medicinal Chemistry, Vol. 32, Issue 12
  • DOI: 10.1021/jm00132a002

Synthesis and Antiviral Activity of 6-Benzyl Analogs of 1-[(2-Hydroxyethoxy)methyl]-5-(phenylthio)thymine (HEPT) as Potent and Selective Anti-HIV-1 Agents
journal, July 1995

  • Tanaka, Hiromichi; Takashima, Hideaki; Ubasawa, Masaru
  • Journal of Medicinal Chemistry, Vol. 38, Issue 15
  • DOI: 10.1021/jm00015a008

Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors
journal, April 2014


A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity
journal, November 2003

  • Parniak, Michael A.; Min, Kyung-Lyum; Budihas, Scott R.
  • Analytical Biochemistry, Vol. 322, Issue 1
  • DOI: 10.1016/j.ab.2003.06.001

Determinants of Mg 2+ -Dependent Activities of Recombinant Human Immunodeficiency Virus Type 1 Integrase
journal, August 2000

  • Leh, Hervé; Brodin, Priscille; Bischerour, Julien
  • Biochemistry, Vol. 39, Issue 31
  • DOI: 10.1021/bi000398b

Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir
journal, May 2010

  • Métifiot, Mathieu; Maddali, Kasthuraiah; Naumova, Alena
  • Biochemistry, Vol. 49, Issue 17
  • DOI: 10.1021/bi100130f

Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by α-Hydroxytropolones
journal, January 2006

  • Semenova, Elena A.; Johnson, Allison A.; Marchand, Christophe
  • Molecular Pharmacology, Vol. 69, Issue 4
  • DOI: 10.1124/mol.105.020321

Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase
journal, January 2012

  • Kirby, Karen A.; Marchand, Bruno; Ong, Yee Tsuey
  • Antimicrobial Agents and Chemotherapy, Vol. 56, Issue 4
  • DOI: 10.1128/AAC.06000-11

Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design
journal, August 2008

  • Bauman, Joseph D.; Das, Kalyan; Ho, William C.
  • Nucleic Acids Research, Vol. 36, Issue 15
  • DOI: 10.1093/nar/gkn464

XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase
journal, January 2013

  • Kuroda, Daniel G.; Bauman, Joseph D.; Challa, J. Reddy
  • Nature Chemistry, Vol. 5, Issue 3
  • DOI: 10.1038/nchem.1559

PHENIX : building new software for automated crystallographic structure determination
journal, October 2002

  • Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
  • DOI: 10.1107/S0907444902016657

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Refinement of Macromolecular Structures by the Maximum-Likelihood Method
journal, May 1997

  • Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3
  • DOI: 10.1107/S0907444996012255

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
journal, May 2007

  • Davis, I. W.; Leaver-Fay, A.; Chen, V. B.
  • Nucleic Acids Research, Vol. 35, Issue Web Server
  • DOI: 10.1093/nar/gkm216

Works referencing / citing this record:

Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV ‐1 RN ase H inhibitors
journal, January 2019

  • Gao, Ping; Wang, Xueshun; Sun, Lin
  • Chemical Biology & Drug Design, Vol. 93, Issue 4
  • DOI: 10.1111/cbdd.13455